MIR2861
gene geneOn this page
Also known as hsa-mir-2861
Summary
MIR2861 (microRNA 2861, HGNC:38221) is a microRNA gene on chromosome 9q34.11.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of target mRNAs. This microRNA may play a role in osteoblast differentiation and a mutation in this gene is associated with osteoporosis. Altered expression of this microRNA has been observed in human cancers, with reduced expression seen in cervical cancer, while expression in papillary thyroid carcinoma (PTC) is increased.
Source: NCBI Gene 100422910 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:38221 |
| Approved symbol | MIR2861 |
| Name | microRNA 2861 |
| Location | 9q34.11 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-2861 |
| Ensembl gene | ENSG00000284547 |
| Ensembl biotype | miRNA |
| OMIM | 613405 |
| Entrez | 100422910 |
| RNAcentral | URS000075ADBF — miRNA, 90 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000636310
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000636310 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003798722 | 127785918 | 127786007 |
Expression profiles
Bgee: expression breadth broad, 64 present calls, max score 78.79.
Top tissues by expression
64 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vermiform appendix | UBERON:0001154 | 78.79 | gold quality |
| placenta | UBERON:0001987 | 75.12 | gold quality |
| blood | UBERON:0000178 | 72.62 | gold quality |
| heart left ventricle | UBERON:0002084 | 71.58 | gold quality |
| gastrocnemius | UBERON:0001388 | 70.07 | gold quality |
| body of pancreas | UBERON:0001150 | 69.46 | gold quality |
| body of stomach | UBERON:0001161 | 69.25 | gold quality |
| right atrium auricular region | UBERON:0006631 | 68.59 | gold quality |
| heart | UBERON:0000948 | 68.09 | gold quality |
| right adrenal gland | UBERON:0001233 | 66.43 | gold quality |
| small intestine | UBERON:0002108 | 64.88 | gold quality |
| tibial artery | UBERON:0007610 | 63.46 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 62.72 | gold quality |
| substantia nigra | UBERON:0002038 | 62.58 | gold quality |
| colon | UBERON:0001155 | 62.55 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 62.23 | gold quality |
| skin of leg | UBERON:0001511 | 61.40 | gold quality |
| minor salivary gland | UBERON:0001830 | 61.30 | gold quality |
| esophagus mucosa | UBERON:0002469 | 61.24 | gold quality |
| body of uterus | UBERON:0009853 | 61.24 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 60.93 | gold quality |
| transverse colon | UBERON:0001157 | 60.92 | gold quality |
| left coronary artery | UBERON:0001626 | 60.86 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 60.67 | gold quality |
| Ammon’s horn | UBERON:0001954 | 60.65 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 60.60 | gold quality |
| left adrenal gland | UBERON:0001234 | 60.55 | gold quality |
| amygdala | UBERON:0001876 | 60.51 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 60.44 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 60.01 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- a homozygous mutation in pre-miR-2861 that blocked expression of miR-2861, targeting HDAC5, was shown to cause primary osteoporosis in 2 related adolescents (PMID:19920351)
- Investigated miRNA deregulation in papillary thyroid carcinoma, particularly with lymph node (LN) metastasis. Expression of either miR-2861 or miR-451 in the LN group was significantly greater than that in the NLN group. (PMID:23609190)
- we have established a serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) that could distinguish CC from CIN and healthy controls with high accuracy. (PMID:26656154)
- the overexpression of miR-2861 and RUNX2 in human Periodontal Ligament Stem Cells cultured in presence of 3D Endobon Xenograft granule scaffold under osteogenic and standard conditions was demonstrated (PMID:28078846)
- Further origin identification revealed that the expression levels of miR-122 in CECs and lymphocytes, miR-140-3p and -2861 in monocytes and CECs, miR-720 in monocytes, and miR-3149 in CECs were greatly up-regulated in the ACS patients compared with the non-ACS patients (PMID:28961259)
- miR-2861 expression was significantly higher in lung cancer stem cells (LCSCs) no matter compared to the differentiation cells or normal cells. HDAC5 expression was positively correlated with miR-2861 in LCSCs, and knockdown of miR-2861 decreased the expression of HDAC5, which implied that HDAC5 may be involved in the differentiation of LCSCs mediated by miR-2861. (PMID:29620443)
- Our study reveals that miR-2861 was lowly expressed in endometriotic tissues, and downregulation of miR-2861 may promote proliferation and inhibit apoptosis of ectopic endometrial cells in endometriosis via upregulation of STAT3 and MMP2. (PMID:30940310)
- SNHG14 induces osteogenic differentiation of human stromal (mesenchymal) stem cells in vitro by downregulating miR-2861. (PMID:32770994)
- LncRNA MIR22HG is downregulated in adenomyosis and upregulates miR-2861 through demethylation to inhibit endometrial cell proliferation. (PMID:33624428)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.